Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 70/100

BD to Present at Cowen 43rd Annual Healthcare Conference BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Cowen 43rd...

Key Takeaway: BD (Becton, Dickinson and Company), a leading global medical technology company, announced its participation in the Cowen 43rd Annual Healthcare Conference scheduled for March 6, 2023. The presentation will be webcast live, with a replay available on the investor relations website. The company emphasizes its commitment to enhancing medical discovery and care delivery through innovative technologies and solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is participating in a prominent healthcare conference, highlighting its role in the industry.
  • The company is committed to improving health care outcomes with innovative solutions.
  • BD has a strong global presence and a dedicated workforce.

Full Press Release Details

FRANKLIN LAKES, N.J. , Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will present at the Cowen 43 rd Annual Healthcare Conference on Monday, March 6, 2023 at 9:50 am Eastern Time .
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be available on the same webpage following its conclusion.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .
Media : Investors :
Troy Kirkpatrick Francesca DeMartino
VP, Public Relations SVP, Head of Investor Relations
858.617.2361 201.847.5743
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When will BD present at the Cowen Healthcare Conference?

BD will present on March 6, 2023, at 9:50 am Eastern Time.

How can I access the live webcast of BD's presentation?

The live webcast can be accessed on BD's investor relations website.

Where can I find the replay of BD's conference presentation?

A replay will be available on the same investor relations webpage after the event.

What is BD's focus in the medical technology field?

BD focuses on improving medical discovery, diagnostics, and care delivery.

How many employees does BD have globally?

BD has approximately 77,000 employees worldwide.

Last updated: Feb 21, 2023